The NIH National Institute of Diabetes and Digestive and Kidney Diseases is seeking a licensee or collaborator for nanobody-antiviral peptide conjugates that act as a one-two punch against viral entry to block HIV from infecting human CD4* T-cells. Potential commercial applications include: a long

Dr. Mark Rohrbaugh, former director of the NIH Office of Technology Transfer (OTT), has been chosen by the Bayh-Dole Coalition as one of their “Faces of American Innovation”. Mark worked at the NIH for over three decades, moving from the National Institute of Allergy and Infectious Diseases, where

The NIH Office of Technology Transfer Director, Dr. Tara Kirby, has been recognized by Intellectual Asset Management (IAM) as a Market Maker of the year. IAM’s Market Makers recognizes the top 40 key deal makers and decision takers in the world, as selected by the IAM editorial team. They consider